RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling is a research paper published in UNC Libraries (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1F30CA243253-01
Validation of WEE1 kinase as a clinical target in KRAS-mutant pancreatic cancer
National Institutes of Health
Grant: 3F32CA200313-02S1
K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies
National Institutes of Health
Grant: 5R35CA232113-04
Targeting undruggable RAS for cancer treatment
National Institutes of Health
Grant: 5P01CA203657-02
Defining RAS isoform- and mutation-specific roles in oncogenesis
National Institutes of Health
Grant: 5U01CA176058-09
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
National Institutes of Health
Grant: 5T32CA009156-20
BASIC MECHANISMS OF VIRAL AND CHEMICAL CARCINOGENESIS
National Institutes of Health
Grant: 3U01CA199235-04S1
Identification of synthetic lethal interactors in pancreatic cancer
National Institutes of Health
Grant: 5P50CA127003-12
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
National Institutes of Health
Grant: 5R01CA175747-05
Mechanisms of PAK1 activation, signaling and tumor resistance
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
Keywords
Sustainable Development Goals